Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma

Trial Overview

Am I Eligible?

Participating US Centers

University of Maryland Medical Center
Marlene and Stewart Greenebaum Comprehensive Cancer Center

This center is currently accepting patients.

Baltimore, MD


Mount Sinai Hospital
Tisch Cancer Institute

This center is currently accepting patients.

New York, NY


Baylor Charles A. Sammons Cancer Center
Baylor Scott & White Health

This center is currently accepting patients.

Dallas, TX


University of Texas Southwest Medical Center (Simmons Cancer Center)

This center is currently accepting patients.

Dallas, TX


Norton Cancer Institute
St. Matthews Campus

This center is currently accepting patients.

Louisville, KY


CHI Health Saint Francis Medical Center

This center is currently accepting patients.

Grand Island, NE


Kaiser Permanente (Moanalua Medical Center)

This center is currently accepting patients.

Honolulu, HI


McFarland Clinic PC

This center is currently accepting patients.

Ames, IA


Stormont-Vail Regional Health Center

This center is currently accepting patients.

Topeka, KS


Kaiser Permanente Northwest

This center is currently accepting patients.

Portland, OR


Prairie Lakes Health Care System

This center is currently accepting patients.

Watertown, SD


Boca Raton Clinical Research (BRCR) Medical Center

This center is currently accepting patients.

Plantation, FL

ACCEPTING

This trial is currently open and accepting patients.



Additional Information
Trial Phase

Phase 3

Trial Enrollment

364 sparks required

Trial Sponsors
  • Karyopharm Therapeutics
Trial Identifiers

Need Help?

(888) 828-2206

Weekdays 9am - 5pm EST

;